Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Exploration of Nonalcoholic Fatty Liver Disease: Insights From Gene Expression and Variation in Morbidly Obese Individuals.

Journal of obesity - 1 Jan 2025

Rafaa Tamadher Abbas, Khudhair Safa Abbas, Mohammed Zahraa Yassen, Suleiman Ahmed AbdulJabbar

Abstract excerpt

Nonalcoholic fatty liver disease (NAFLD) is a common liver condition resulting from metabolic syndrome characterized by fat accumulation in the liver. It is often associated with obesity and diabetes, contributing to hepatic steatosis in liver cells. The prevalence of NAFLD is increasing globally, with 32% of the adult population affected. Genetic modifiers, such as single nucleotide polymorphisms, can increase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to LIPC gene
Share to SERPINE1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity, Morbid

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 40365443
DOI: 10.1155/jobe/9245699
PMCID: PMC12069845

Genes

AKR1D1
LIPC
SERPINE1
DGAT2
UGT2B17

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Exploration of Nonalcoholic Fatty Liver Disease: Insights From Gene Expression and Variation in Morbidly Obese Individuals.PMID 40365443Read ↗

Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.Semantic proximity Read ↗

Advances in the genetics of nonalcoholic fatty liver disease.Semantic proximity Read ↗

Unraveling the pathogenesis of non‐alcoholic fatty liver diseases through genome‐wide association studiesSemantic proximity Read ↗

Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease.Semantic proximity Read ↗

Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.Semantic proximity Read ↗

Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.Semantic proximity Read ↗

Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems BiologySemantic proximity Read ↗

Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and TherapeuticsSemantic proximity Read ↗

GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.Semantic proximity Read ↗

Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factorsSemantic proximity Read ↗

Genetics and epigenetics purpose in nonalcoholic fatty liver disease.Semantic proximity Read ↗

Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.